Pharma-Bio Serv (PBSV) Return on Capital Employed Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 70.00 |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | -184.00 |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 453.00 |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 36.00 |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 128.00 |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 1,724.00 |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 150.00 |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 154.00 |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | 116.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 116.00 |
| Oct 31, 2025 | 356.00 |
| Jul 31, 2025 | 260.00 |
| Apr 30, 2025 | -334.00 |
| Jan 31, 2025 | -958.00 |
| Oct 31, 2024 | -1,516.00 |
| Jul 31, 2024 | -1,569.00 |
| Apr 30, 2024 | -872.00 |
| Jan 31, 2024 | -359.00 |
| Oct 31, 2023 | -17.00 |
| Jul 31, 2023 | 2,861.00 |
| Apr 30, 2023 | 2,664.00 |
| Jan 31, 2023 | 2,425.00 |
| Oct 31, 2022 | 2,273.00 |
| Jul 31, 2022 | -2,520.00 |
| Apr 30, 2022 | -2,611.00 |
| Jan 31, 2022 | -2,665.00 |
| Oct 31, 2021 | -2,483.00 |
| Jul 31, 2021 | -553.00 |
| Apr 30, 2021 | -226.00 |
| Jan 31, 2021 | 82.00 |
| Oct 31, 2020 | 87.00 |
| Jul 31, 2020 | 219.00 |
| Apr 30, 2020 | -93.00 |
| Jan 31, 2020 | 14.00 |
| Oct 31, 2019 | 1,341.00 |
| Jul 31, 2019 | 1,541.00 |
| Apr 30, 2019 | 2,164.00 |
| Jan 31, 2019 | 2,094.00 |
| Oct 31, 2018 | -207.00 |
| Jul 31, 2018 | -143.00 |
| Apr 30, 2018 | -646.00 |
| Jan 31, 2018 | -980.00 |
| Oct 31, 2017 | -330.00 |
| Apr 30, 2013 | -882.00 |
| Jan 31, 2013 | -640.00 |
| Oct 31, 2012 | 239.00 |